Vimarsana
Biggest News Aggregation in the World

Page 2 - German Commercial Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from German Commercial Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In German Commercial Code Today - Breaking & Trending Today

Va Q tec : Report of the Supervisory Board for the financial year 2023 (convenience translation only) - Vimarsana News

Va Q tec : Report of the Supervisory Board for the financial year 2023 (convenience translation only)

Published: May 7, 2024

1.1 Supervisory Board report Dear shareholders, The Supervisory Board held a total of five meetings in the 2023 financial year. The...

Source: marketscreener.com
Related Topics:
Matthias WittkowskiWinfried KlarJoachim KuhnCamilla Macapili LanguilleInsook YooAli FarahaniInternational Financial Reporting StandardsDistrict CourtGerman Stock Corporation Act AktVogel Convention CenterEuropean UnionQ Tec GroupSupervisory BoardAnnual General MeetingManagement BoardGerman Corporate Governance CodeJarl DahlforsGerman Stock Corporation ActDeputy ChairmanChief Financial OfficerGerman Act ImplementingSecond Shareholder Rights DirectiveGerman Commercial CodePartner Gmbh Wirtschaftspr
SAF Holland : Information on Agenda item 1 pursuant to section 124a sentence 1 no. 2 of the German Stock Corporation Act (AktG) - Vimarsana News

SAF Holland : Information on Agenda item 1 pursuant to section 124a sentence 1 no. 2 of the German Stock Corporation Act (AktG)

Published: May 6, 2024

Convenience Translation SAF-HOLLAND SE Bessenbach ISIN: DE000SAFH001 WKN: SAFH00 ...

Source: marketscreener.com
Related Topics:
German Stock Corporation Act AktGerman Stock CorporationGerman Stock Corporation Act AktiengesetzConvenience TranslationGeneral MeetingManagement BoardGerman Commercial CodeSupervisory BoardGerman Stock Corporation Act
BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Collaborations GmbH on the domination and profit and loss transfer agreement pursuant to Section 293a AktG - Vimarsana News

BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Collaborations GmbH on the domination and profit and loss transfer agreement pursuant to Section 293a AktG

Published: May 3, 2024

English Convenience Translation - the German language joint report is decisive Joint report of the Management Board of BioNTech SE, Mainz, and the management of...

Source: marketscreener.com
Related Topics:
Nordrhein WestfalenMichael MotschmannRyan RichardsonJames RyanSean MarettJens HolsteinNicola BlackwoodRudolf StaudiglAnja MorawietzUlrich WandschneiderDirk SchreiberHelmut JeggleSierk PoettingArticles Of AssociationRegister Local CourtBiontech Or Controlling CompanyRegister Of The Controlled CompanyRegister Of The Local CourtMainz Local CourtGerman Stock Corporation Act AktiengesetzArticles Of Association BiontechControlling CompanyBonn Local CourtBiontech Collaborations Or Controlled CompanyEnglish Convenience Translation
BioNTech : Annual Financial Statements as of 31 December 2023 - Vimarsana News

BioNTech : Annual Financial Statements as of 31 December 2023

Published: May 3, 2024

Translation from the German language Annual Financial Statements of BioNTech SE, Mainz, December 31, 2023 Translation...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesCity OfMedilink Therapeutics Suzhou CoMainz Local CourtBiontech Biontainer Holding GmbBiontech United States HoldingInstadeep LtdGerman Stock Corporation Act AktOrganisation For EconomicDuality Biologics Suzhou CoBiotheus IncFinancial StatementsFinancial PositionSeparate Financial StatementsAnnual Financial StatementsGerman Commercial CodeGerman Stock Corporation ActDepositary SharesNasdaq Global Select MarketMainz Based CompanyAccounting PoliciesEconomic Co OperationBase ErosionProfit Shifting
BioNTech : Annual financial statements of BioNTech SE as of 31 December 2023 - Vimarsana News

BioNTech : Annual financial statements of BioNTech SE as of 31 December 2023

Published: May 3, 2024

Translation from the German language Annual Financial Statements of BioNTech SE, Mainz, December 31, 2023 Translation...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesCity OfBiontech Biontainer Holding GmbMainz Local CourtMedilink Therapeutics Suzhou CoDuality Biologics Suzhou CoBiotheus IncGerman Stock Corporation Act AktOrganisation For EconomicInstadeep LtdBiontech United States HoldingFinancial StatementsFinancial PositionSeparate Financial StatementsAnnual Financial StatementsGerman Commercial CodeGerman Stock Corporation ActDepositary SharesNasdaq Global Select MarketMainz Based CompanyAccounting PoliciesEconomic Co OperationBase ErosionProfit Shifting